跳至主要内容
临床试验/JPRN-UMIN000045728
JPRN-UMIN000045728已完成未知

The impact of the improvement of glycometabolism in patients with type 2 diabetes on sleep disturbance including sleep disordered breathing following an admission to control their glucose metabolism. - The impact of the improvement of glycometabolism on sleep disturbance including sleep apnea.

ihon University of Medicine0 个研究点目标入组 80 人开始时间: 2021年10月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients who were already diagnosed as sleep apnea syndrome and treated. 2.Patients with diabetes who were diagnosed as not tyoe 2 but the others. 3.Patients with diabetic ketosis or ketoacidosis 4.Patients with cancer 5.Patients taking corticosteroids. 6.Patients on oxygen therapy 7.Patients with hemodialysis 8.Patients with a cardiac pacemaker 9.Premenoposal female 10. Patients with physical activity restrictions due to disability 11.Patients who refuse to participate in this trial. 12. Patients who are judged to be inappropriate as a candidate by the doctor.

研究者

发起方
ihon University of Medicine

相似试验